Literature DB >> 10728678

CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.

L O'Connor1, A W Harris, A Strasser.   

Abstract

The tumor suppressor p53 exerts its antioncogenic effects in cells chiefly by regulating their progression through the cell cycle and by inducing cell death. It has been claimed that p53-transduced apoptosis involves the death receptor CD95 (Fas/APO-1). We report that thymocytes from mice lacking functional Fas ligand (gld) show normal sensitivity to apoptosis transduced by p53, and that hepatocytes fromp53-/- mice have normal sensitivity to apoptosis triggered through ligation of CD95. p53 and CD95, therefore, function in independent pathways to cell death in these diverse cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728678

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation.

Authors:  F Piu; A Aronheim; S Katz; M Karin
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 2.  Deconstructing p53 transcriptional networks in tumor suppression.

Authors:  Kathryn T Bieging; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2011-12-09       Impact factor: 20.808

3.  EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.

Authors:  Kui Su; Qian Yuan; Huan Hou; Changhong Ke; Chaohong Huang; Shuyi Li; Jianwu Sun; Xin Yuan; Yue Lin; Yiqing Chen; Huijuan Xin; Xiaoping Liang; Zhiyun Du; Zhengqiang Yuan
Journal:  J Mol Med (Berl)       Date:  2022-03-05       Impact factor: 4.599

4.  Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.

Authors:  Hector Guillen-Ahlers; Mark A Suckow; Francis J Castellino; Victoria A Ploplis
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

5.  Bak compensated for Bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during Withanolide D-induced apoptosis.

Authors:  Susmita Mondal; Kaushik Bhattacharya; Asish Mallick; Rajender Sangwan; Chitra Mandal
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression.

Authors:  Frédéric Lebrun-Julien; Ueli Suter
Journal:  ASN Neuro       Date:  2015-06-30       Impact factor: 4.146

7.  Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients.

Authors:  G Scaini; G R Fries; S S Valvassori; C P Zeni; G Zunta-Soares; M Berk; J C Soares; J Quevedo
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

8.  Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane.

Authors:  Yang Su; Katharina Tatzel; Xuejun Wang; Brian Belt; Pratibha Binder; Lindsay Kuroki; Matthew A Powell; David G Mutch; William G Hawkins; Dirk Spitzer
Journal:  Oncotarget       Date:  2016-05-24

Review 9.  Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis.

Authors:  Ishita Gupta; Kanika Singh; Nishant K Varshney; Sameena Khan
Journal:  Front Cell Dev Biol       Date:  2018-02-09

Review 10.  Getting TRAIL back on track for cancer therapy.

Authors:  J Lemke; S von Karstedt; J Zinngrebe; H Walczak
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.